Skip to main content

Table 1 Assessment of eligible trials according to Jadad grading

From: Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis

Study

Random sequence generation

Random masking

Double-blind

Withdrawals and dropouts

Sum (Jadad score)

ABCSG-12 [15]

2

2

0

1

5

AZURE [14]

2

2

0

1

5

E-ZO-FAST [20]

1

2

0

1

4

Z-FAST [17]

1

0

0

1

2

ZO-FAST [16]

1

0

0

1

2

Leal et al., [19]

1

2

0

1

4

Aft et al., [18]

1

0

1

1

3

Talahashi et al., [22]

1

0

0

1

2